Regeneron Pharmaceuticals Net Income 2006-2018 | REGN

Regeneron Pharmaceuticals annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Regeneron Pharmaceuticals net income for the quarter ending June 30, 2018 was $0.551B, a 42.21% increase year-over-year.
  • Regeneron Pharmaceuticals net income for the twelve months ending June 30, 2018 was $1.591B, a 37.82% increase year-over-year.
  • Regeneron Pharmaceuticals annual net income for 2017 was $1.199B, a 33.83% increase from 2016.
  • Regeneron Pharmaceuticals annual net income for 2016 was $0.896B, a 40.79% increase from 2015.
  • Regeneron Pharmaceuticals annual net income for 2015 was $0.636B, a 88.11% increase from 2014.
Regeneron Pharmaceuticals Annual Net Income
(Millions of US $)
2017 $1,199
2016 $896
2015 $636
2014 $338
2013 $414
2012 $750
2011 $-222
2010 $-104
2009 $-68
2008 $-79
2007 $-107
2006 $-102
2005 $-95
Regeneron Pharmaceuticals Quarterly Net Income
(Millions of US $)
Q2 2018 $551
Q1 2018 $478
Q4 2017 $174
Q3 2017 $388
Q2 2017 $388
Q1 2017 $249
Q4 2016 $253
Q3 2016 $265
Q2 2016 $196
Q1 2016 $181
Q4 2015 $155
Q3 2015 $210
Q2 2015 $195
Q1 2015 $76
Q4 2014 $90
Q3 2014 $83
Q2 2014 $96
Q1 2014 $68
Q4 2013 $86
Q3 2013 $141
Q2 2013 $87
Q1 2013 $99
Q4 2012 $470
Q3 2012 $191
Q2 2012 $77
Q1 2012 $12
Q4 2011 $-53
Q3 2011 $-62
Q2 2011 $-63
Q1 2011 $-43
Q4 2010 $-15
Q3 2010 $-34
Q2 2010 $-25
Q1 2010 $-31
Q4 2009 $-36
Q3 2009 $-1
Q2 2009 $-15
Q1 2009 $-15
Q4 2008 $-30
Q3 2008 $-19
Q2 2008 $-19
Q1 2008 $-12
Q4 2007 $-14
Q3 2007 $-36
Q2 2007 $-27
Q1 2007 $-30
Q4 2006 $-31
Q3 2006 $-27
Q2 2006 $-24
Q1 2006 $-20
Q4 2005 $-30
Q3 2005 $-35
Q2 2005 $-27
Q1 2005 $-4
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $42.162B $5.872B
Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of obesity, rheumatoid arthritis, cancer, and asthma and has preclinical programs in other diseases and disorders.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $134.121B 15.40
Gilead Sciences (GILD) United States $98.029B 10.88
Biogen (BIIB) United States $69.905B 14.82
Celgene (CELG) United States $61.586B 12.30
Illumina (ILMN) United States $52.663B 65.98
Vertex Pharmaceuticals (VRTX) United States $46.555B 105.91
Alexion Pharmaceuticals (ALXN) United States $28.640B 21.53
BioMarin Pharmaceutical (BMRN) United States $17.338B 0.00
Incyte (INCY) United States $14.132B 474.86
Seattle Genetics (SGEN) United States $12.470B 0.00
Sarepta Therapeutics (SRPT) United States $10.172B 0.00
Exact Sciences (EXAS) United States $9.666B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.388B 0.00
BeiGene (BGNE) Cayman Islands $8.928B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.881B 57.03
QIAGEN (QGEN) Netherlands $8.541B 27.92
Bio-Techne Corp (TECH) United States $7.560B 50.56
Bluebird Bio (BLUE) United States $7.552B 0.00
Alkermes (ALKS) Ireland $6.550B 0.00
Galapagos (GLPG) Belgium $5.752B 0.00
Ligand Pharmaceuticals (LGND) United States $5.663B 50.16
Exelixis (EXEL) United States $5.028B 16.38
Ultragenyx Pharmaceutical (RARE) United States $4.448B 0.00
Immunomedics (IMMU) United States $4.058B 0.00
Amarin (AMRN) Ireland $3.625B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.478B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.378B 0.00
Myriad Genetics (MYGN) United States $3.328B 37.25
Emergent Biosolutions (EBS) United States $3.324B 26.47
Horizon Pharma Public (HZNP) Ireland $3.201B 18.12
Blueprint Medicines (BPMC) United States $3.142B 0.00
Array BioPharma (ARRY) United States $3.134B 0.00
Akcea Therapeutics (AKCA) United States $2.836B 0.00
Ascendis Pharma (ASND) Denmark $2.805B 0.00
Reata Pharmaceuticals (RETA) United States $2.701B 0.00
China Biologic Products (CBPO) China $2.675B 17.67
Acceleron Pharma (XLRN) United States $2.669B 0.00
MyoKardia (MYOK) United States $2.603B 0.00
Halozyme Therapeutics (HALO) United States $2.583B 34.42
Genomic Health (GHDX) United States $2.542B 141.78
ARGENX SE-ADR (ARGX) Netherlands $2.505B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.481B 0.00
AnaptysBio (ANAB) United States $2.451B 0.00
Medicines (MDCO) United States $2.423B 0.00
Repligen (RGEN) United States $2.412B 80.99
Amicus Therapeutics (FOLD) United States $2.379B 0.00
REGENXBIO (RGNX) United States $2.318B 36.42
CRISPR THERAPTC (CRSP) Switzerland $2.137B 0.00
Arena Pharmaceuticals (ARNA) United States $2.115B 0.00
Spark Therapeutics (ONCE) United States $2.105B 0.00
Global Blood Therapeutics (GBT) United States $2.103B 0.00
Cambrex (CBM) United States $2.095B 16.80
Momenta Pharmaceuticals (MNTA) United States $2.091B 0.00
Allakos (ALLK) United States $1.968B 0.00
Denali Therapeutics (DNLI) United States $1.966B 0.00
Mirati Therapeutics (MRTX) United States $1.925B 0.00
G1 THERAPEUTICS (GTHX) United States $1.925B 0.00
Atara Biotherapeutics (ATRA) United States $1.845B 0.00
Rubius Therapeutics (RUBY) United States $1.830B 0.00
Myovant Sciences (MYOV) United Kingdom $1.806B 0.00
Puma Biotechnology (PBYI) United States $1.802B 0.00
Solid Biosciences (SLDB) United States $1.758B 0.00
Insmed (INSM) United States $1.733B 0.00
Clovis Oncology (CLVS) United States $1.718B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.662B 0.00
Sangamo Therapeutics (SGMO) United States $1.632B 0.00
WAVE Life Sciences (WVE) Singapore $1.619B 0.00
Aimmune Therapeutics (AIMT) United States $1.605B 0.00
Innoviva (INVA) United States $1.528B 9.81
Deciphera Pharmaceuticals (DCPH) United States $1.503B 0.00
UniQure (QURE) Netherlands $1.496B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.458B 0.00
Editas Medicine (EDIT) United States $1.456B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.440B 0.00
Audentes Therapeutics (BOLD) United States $1.405B 0.00
IMMURON LTD (IMRN) Australia $1.389B 0.00
DBV Technologies (DBVT) France $1.378B 0.00
Lion Biotechnologies (IOVA) United States $1.257B 0.00
Cellectis (CLLS) France $1.217B 0.00
AVROBIO (AVRO) United States $1.200B 0.00
NeoGenomics (NEO) United States $1.188B 207.86
Intra-Cellular Therapies (ITCI) United States $1.178B 0.00
Intellia Therapeutics (NTLA) United States $1.170B 0.00
Viking Therapeutics (VKTX) United States $1.170B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.165B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.143B 0.00
Geron (GERN) United States $1.138B 0.00
Retrophin (RTRX) United States $1.134B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.123B 0.00
Athenex (ATNX) United States $1.119B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.099B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.094B 0.00
Coherus BioSciences (CHRS) United States $1.092B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.071B 2045.00
Apellis Pharmaceuticals (APLS) United States $1.069B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.055B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.043B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.982B 0.00
Revance Therapeutics (RVNC) United States $0.935B 0.00
Cara Therapeutics (CARA) United States $0.932B 0.00
Acorda Therapeutics (ACOR) United States $0.890B 18.56
Aptinyx (APTX) United States $0.884B 0.00
Fate Therapeutics (FATE) United States $0.870B 0.00
CytomX Therapeutics (CTMX) United States $0.832B 0.00
Heska (HSKA) United States $0.820B 70.60
InflaRx (IFRX) Germany $0.787B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.784B 0.00
Dynavax Technologies (DVAX) United States $0.776B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.721B 0.00
Epizyme (EPZM) United States $0.712B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.708B 0.00
Novavax (NVAX) United States $0.708B 0.00
UNITY Biotechnology (UBX) $0.676B 0.00
UROGEN PHARMA (URGN) Israel $0.674B 0.00
MiMedx (MDXG) United States $0.666B 28.57
ObsEva SA (OBSV) Switzerland $0.658B 0.00
Abeona Therapeutics (ABEO) United States $0.658B 0.00
Verastem (VSTM) United States $0.658B 0.00
Kura Oncology (KURA) United States $0.655B 0.00
Mesoblast (MESO) Australia $0.648B 0.00
ANI Pharmaceuticals (ANIP) United States $0.633B 12.54
Vericel (VCEL) United States $0.632B 0.00
PRINCIPIA BIOPH (PRNB) United States $0.626B 0.00
Anika Therapeutics (ANIK) United States $0.618B 26.00
Scholar Rock Holding (SRRK) United States $0.609B 0.00
Replimune (REPL) United States $0.606B 0.00
Arcus Biosciences (RCUS) United States $0.599B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.599B 0.00
BeyondSpring (BYSI) United States $0.572B 0.00
Prothena (PRTA) Ireland $0.568B 0.00
Senesco Technologies (ELOX) United States $0.555B 0.00
AC Immune SA (ACIU) Switzerland $0.551B 0.00
Stemline Therapeutics (STML) United States $0.530B 0.00
Arbutus Biopharma (ABUS) Canada $0.526B 0.00
RA PHARMCTL INC (RARX) United States $0.522B 0.00
Zealand Pharma (ZEAL) Denmark $0.517B 0.00
Zymeworks (ZYME) Canada $0.501B 0.00
MediciNova (MNOV) United States $0.496B 0.00
Sorrento Therapeutics (SRNE) United States $0.496B 85.00
Cytokineticsorporated (CYTK) United States $0.492B 0.00
Five Prime Therapeutics (FPRX) United States $0.491B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.486B 0.00
Aduro Biotech (ADRO) United States $0.470B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.466B 0.00
Kindred Biosciences (KIN) United States $0.457B 0.00
Inovio Pharmaceuticals (INO) United States $0.443B 0.00
ResTORbio (TORC) United States $0.438B 0.00
Sinovac Biotech (SVA) China $0.430B 0.00
Merus (MRUS) Netherlands $0.430B 0.00
Syros Pharmaceuticals (SYRS) United States $0.426B 0.00
Eidos Therapeutics (EIDX) United States $0.408B 0.00
Magenta Therapeutics (MGTA) United States $0.395B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.393B 0.00
Kezar Life Sciences (KZR) United States $0.390B 0.00
Osiris Therapeutics (OSIR) United States $0.389B 0.00
Evelo Biosciences (EVLO) United States $0.389B 0.00
Kadmon Holdings (KDMN) United States $0.386B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.385B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.384B 0.00
Albireo Pharma (ALBO) United States $0.380B 0.00
Adverum Biotechnologies (ADVM) United States $0.376B 0.00
PDL BioPharma (PDLI) United States $0.375B 5.27
Unum Therapeutics (UMRX) United States $0.375B 0.00
Cellular Biomedicine (CBMG) United States $0.372B 0.00
MeiraGTx Holdings (MGTX) United States $0.360B 0.00
Selecta Biosciences (SELB) United States $0.358B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.337B 0.00
Synlogic (SYBX) United States $0.333B 0.00
Seres Therapeutics (MCRB) United States $0.323B 0.00
Liquidia Technologies (LQDA) United States $0.317B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.312B 0.00
BioTime (BTX) United States $0.310B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.309B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.298B 0.00
MannKind (MNKD) United States $0.294B 0.00
Celcuity (CELC) United States $0.293B 0.00
ADMA Biologics Inc (ADMA) United States $0.292B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.288B 0.00
TOCAGEN INC (TOCA) United States $0.275B 0.00
Celyad SA (CYAD) Belgium $0.273B 0.00
Axovant Sciences (AXON) United Kingdom $0.271B 0.00
Athersys (ATHX) United States $0.270B 0.00
Kala Pharmaceuticals (KALA) United States $0.267B 0.00
Menlo Therapeutics (MNLO) United States $0.267B 0.00
Mersana Therapeutics (MRSN) United States $0.263B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.260B 0.00
Idera Pharmaceuticals (IDRA) United States $0.259B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.258B 0.00
NantKwest (NK) United States $0.256B 0.00
Kamada (KMDA) Israel $0.246B 19.06
Agenus (AGEN) United States $0.244B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.243B 0.00
Allena Pharmaceuticals (ALNA) United States $0.218B 0.00
Protagonist Therapeutics (PTGX) United States $0.209B 0.00
Constellation Pharmaceuticals (CNST) United States $0.205B 0.00
Monster Digital (INNT) United States $0.205B 0.00
Palatin Technologies (PTN) United States $0.204B 8.42
ChromaDex (CDXC) United States $0.204B 0.00
Compugen (CGEN) Israel $0.200B 0.00
Spero Therapeutics (SPRO) United States $0.199B 0.00
Strongbridge Biopharma (SBBP) United States $0.199B 0.00
Clearside Biomedical (CLSD) United States $0.198B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.197B 0.00
Cue Biopharma (CUE) United States $0.184B 0.00
Krystal Biotech (KRYS) United States $0.183B 0.00
Enzo Biochem (ENZ) United States $0.181B 0.00
Cohbar (CWBR) United States $0.181B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) $0.176B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.173B 0.00
Signal Genetics (MGEN) United States $0.173B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.169B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.169B 0.00
BioDelivery Sciences (BDSI) United States $0.165B 0.00
Eleven Biotherapeutics (SESN) United States $0.161B 0.00
Cerecor (CERC) United States $0.161B 19.21
Mustang Bio (MBIO) United States $0.161B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.158B 0.00
Pfenex (PFNX) United States $0.156B 0.00
Pluristem Therapeutics (PSTI) Israel $0.149B 0.00
Trevena (TRVN) United States $0.148B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.147B 0.00
OVID THERAPEUTC (OVID) United States $0.147B 0.00
Checkpoint Therapeutics (CKPT) United States $0.146B 0.00
PSivida (EYPT) United States $0.145B 0.00
Intec Pharma (NTEC) Israel $0.144B 0.00
Provention Bio (PRVB) United States $0.142B 0.00
XOMA (XOMA) United States $0.140B 14.82
Organovo Holdings (ONVO) United States $0.135B 0.00
Tapimmune (TPIV) United States $0.132B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.130B 0.00
Motif Bio Plc (MTFB) United States $0.128B 0.00
Catalyst Biosciences (CBIO) United States $0.122B 0.00
VBI Vaccines (VBIV) United States $0.122B 0.00
BioXcel Therapeutics (BTAI) United States $0.119B 0.00
Anavex Life Sciences (AVXL) United States $0.116B 0.00
Cidara Therapeutics (CDTX) United States $0.116B 0.00
Aptevo Therapeutics (APVO) United States $0.114B 0.00
Protalix BioTherapeutics (PLX) Israel $0.107B 0.00
Cel-Sci (CVM) United States $0.105B 0.00
Alcobra (ARCT) United States $0.104B 0.00
Neothetics (EVFM) United States $0.104B 0.00
ARIDIS PHARMACT (ARDS) United States $0.102B 0.00
Leap Therapeutics (LPTX) United States $0.100B 0.00
ScPharmaceuticals (SCPH) United States $0.097B 0.00
XBiotech (XBIT) United States $0.097B 0.00
Proteostasis Therapeutics (PTI) United States $0.092B 0.00
Aptose Biosciences (APTO) Canada $0.091B 0.00
Applied Genetic Technologies (AGTC) United States $0.091B 0.00
Chiasma (CHMA) United States $0.089B 0.00
NewLink Genetics (NLNK) United States $0.089B 0.00
Vaccinex (VCNX) United States $0.088B 0.00
Prima BioMed (IMMP) Australia $0.088B 0.00
Ophthotech (OPHT) United States $0.087B 0.57
OncoMed Pharmaceuticals (OMED) United States $0.087B 0.00
Axsome Therapeutics (AXSM) United States $0.087B 0.00
Sophiris Bio (SPHS) United States $0.084B 0.00
VolitionRX (VNRX) Singapore $0.083B 0.00
Cocrystal Pharma (COCP) United States $0.082B 0.00
Evogene (EVGN) Israel $0.081B 0.00
Fortress Biotech (FBIO) United States $0.080B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.080B 0.00
Asterias Biotherapeutics (AST) United States $0.078B 0.00
OncoSec Medical (ONCS) United States $0.075B 0.00
Orgenesis (ORGS) United States $0.075B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.074B 0.00
Celldex Therapeutics (CLDX) United States $0.073B 0.00
Alimera Sciences (ALIM) United States $0.072B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.070B 0.00
Oncobiologics (ONS) United States $0.069B 0.00
Oncolytics Biotech (ONCY) Canada $0.069B 0.00
CorMedix Inc (CRMD) United States $0.068B 0.00
TRACON Pharmaceuticals (TCON) United States $0.064B 0.00
Bellerophon Therapeutics (BLPH) United States $0.064B 0.00
Novelion Therapeutics (NVLN) Canada $0.062B 0.00
Caladrius Biosciences (CLBS) United States $0.061B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.060B 0.00
Entera Bio (ENTX) Israel $0.058B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.057B 0.00
Curis (CRIS) United States $0.054B 0.00
VIVUS (VVUS) United States $0.053B 0.00
AZURRX BIOPHARM (AZRX) United States $0.050B 0.00
Celsion (CLSN) United States $0.049B 0.00
Advaxis (ADXS) United States $0.049B 0.00
Zosano Pharma (ZSAN) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
GTx (GTXI) United States $0.045B 0.00
Moleculin Biotech (MBRX) United States $0.044B 0.00
BioPharmX (BPMX) United States $0.041B 0.00
Eyenovia (EYEN) United States $0.041B 0.00
Aileron Therapeutics (ALRN) United States $0.041B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.038B 0.00
AquaBounty Technologies (AQB) United States $0.036B 0.00
VistaGen Therapeutics (VTGN) United States $0.035B 0.00
CytRx (CYTR) United States $0.035B 0.00
GENPREX INC (GNPX) United States $0.034B 0.00
Proteon Therapeutics (PRTO) United States $0.033B 0.00
Gemphire Therapeutics (GEMP) United States $0.033B 0.00
Vical (VICL) United States $0.030B 0.00
VTv Therapeutics (VTVT) United States $0.029B 0.00
AEterna Zentaris (AEZS) United States $0.028B 57.00
Benitec Biopharma (BNTC) Australia $0.028B 0.00
OvaScience (OVAS) United States $0.027B 0.00
Cellect Biotechnology (APOP) Israel $0.027B 0.00
Soligenix (SNGX) United States $0.026B 0.00
Edge Therapeutics (EDGE) United States $0.024B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.024B 0.00
ATyr Pharma (LIFE) United States $0.023B 0.00
Arsanis (ASNS) United States $0.023B 0.00
RestorGenex (DFFN) United States $0.023B 0.00
Galena Biopharma (SLS) United States $0.023B 0.00
Cleveland BioLabs (CBLI) United States $0.023B 0.00
Fibrocell Science Inc (FCSC) United States $0.022B 0.00
Adial Pharmaceuticals (ADIL) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Histogenics (HSGX) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
Prana Biotechnology (PRAN) Australia $0.018B 0.00
AmpliPhi Biosciences (APHB) United States $0.017B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.016B 0.00
Neuralstem (CUR) United States $0.016B 0.00
Therapix Biosciences (TRPX) Israel $0.016B 5.84
Novogen (KZIA) Australia $0.016B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Vital Therapies (VTL) United States $0.012B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Oragenics (OGEN) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
IBio (IBIO) United States $0.010B 0.00
Synthetic Biologics (SYN) United States $0.010B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.009B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.007B 0.00
Aytu Bioscience (AYTU) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00